Nick Haggar Appointed CEO of Zentiva

 

Zentiva is very pleased to announce the appointment of Nick Haggar to the role of Chief Executive Officer (CEO), effective as of February 11th, 2019. Nick joins from InsudPharma where he has been CEO from 2016-2019. He has worked in the pharmaceutical and healthcare industry for more than 30 years and has both a strong commercial track-record with leadership positions in Sandoz (Novartis), GlaxoSmithKline and Ranbaxy, and technical know-how having commenced his career in technical operations at Baxter Healthcare. He was also President of Medicines for Europe(former EGA) during 2014-2015. Nick will be based in Prague and will report to the Advisory Committee of Zentiva.

Nick commented: “I am extremely excited to join Zentiva on its new journey. In the months ahead, we will expand our reach, increase our productivity and accelerate our growth as we help support people’s daily healthcare needs.”

Zentiva was carved-out from Sanofi in October last year. The Group is now backed by Advent International, one of the world’s largest and most experienced global private equity investors.




I want to grow my online platform to create awareness about ethical consumerism, environmentalism, and the plant-based lifestyle. My main mission is to share information that empowers people to make better choices and create a VEG NEW WORLD :)


Your support is vital and is helping me share the collected information with thousands of readers and viewers. I try to deliver exclusive stories and relevant content in a challenging commercial environment. Your contribution helps me to cover the costs that my service requires. Please consider contributing (no matter how small) to keep the information flowing so you can remain informed and have life changing interviews and stories to share.

Related articles